Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Pediatrics & Neonatal Biology Open Access Research Article 21 min read

The Impact of Blood Transfusion on Pediatric Severe Malaria Cases with HIV Co Infection A Review

Emmanuel Ifeanyi Obeagu * and Getrude Uzoma Obeagu*
* Corresponding author
ISSN: 2640-2726  10.23880/pnboa-16000194  Received: March 04, 2024  Published: March 22, 2024
 — views
 96 references
PDF
Keywords
Pediatric Malaria Malaria HIV Blood Transfusion Transfusion Therapy Pediatric Healthcare Antiretroviral Therapy
Abstract

Pediatric severe malaria cases complicated by HIV co-infection present a formidable healthcare challenge, necessitating a nuanced and comprehensive approach to treatment. This review critically examines the efficacy of blood transfusion as a therapeutic intervention in managing severe malaria among pediatric patients co-infected with HIV. We delve into the current state of knowledge, discussing the immunological complexities, potential interactions with antiretroviral therapy, and the inherent challenges associated with this dual burden of disease. Despite the complexities, blood transfusion remains a vital element in addressing severe anemia in pediatric malaria. This review synthesizes existing literature, identifies gaps in knowledge, and proposes avenues for future research to enhance our understanding and optimize treatment strategies for this vulnerable population.

Emmanuel Ifeanyi Obeagu1* and Getrude Uzoma Obeagu2

Introduction

Pediatric severe malaria, exacerbated by co-infection with Human Immunodeficiency Virus (HIV), poses a substantial threat to child health globally [1, 2]. Severe malaria remains a leading cause of morbidity and mortality among children under the age of five, particularly in malaria- endemic regions [3, 4]. The complexity intensifies when these cases are complicated by the presence of HIV, creating a clinical scenario that demands specialized attention. While advances in healthcare have significantly improved our ability to manage both severe malaria and HIV independently, the interplay between these two infections raises unique challenges. Severe malaria often leads to life-threatening complications, with anemia being a predominant feature. In pediatric cases, where the immune system is still developing, the consequences of severe malaria are particularly pronounced. The co-existence of HIV further complicates the clinical picture, influencing immune responses and disease progression [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. Blood transfusion has long been a cornerstone in the management of severe malaria-related anemia in pediatric patients. However, the effectiveness of this intervention in the context of HIV co-infection remains an area of ongoing investigation and debate. This review seeks to critically analyze the current state of knowledge surrounding the utilization of blood transfusion as a therapeutic strategy for pediatric severe malaria cases with concurrent HIV infection.

Blood Transfusion in Severe Malaria

Severe malaria, characterized by life-threatening complications such as cerebral malaria, severe anemia, and respiratory distress, remains a significant public health concern, particularly in the pediatric population. Among the various complications, severe anemia often necessitates therapeutic interventions, with blood transfusion being a pivotal component of the management strategy. Blood transfusion serves as a vital therapeutic measure in severe malaria cases, aiming to address the profound anemia that can result from the destruction of red blood cells by the Plasmodium parasite. In pediatric patients, whose physiological reserves are limited, restoring hemoglobin levels becomes paramount to ensure adequate oxygen delivery to vital organs. The timing and indications for blood transfusion in severe malaria depend on several factors, including the severity of anemia, clinical presentation, and the response to other therapeutic interventions. Transfusion may be indicated when hemoglobin levels fall below a certain threshold, typically defined by clinical guidelines [17, 18, 19, 20, 21, 22, 23, 24, 25, 26].

Despite its therapeutic benefits, blood transfusion in severe malaria is not without challenges. Access to safe and compatible blood, particularly in resource-limited settings where malaria is endemic, poses a logistical challenge. Additionally, transfusion-related complications, such as transfusion-transmitted infections, must be carefully considered. In pediatric patients, the efficacy of blood transfusion in severe malaria is underscored by its potential to rapidly reverse life-threatening anemia and improve overall clinical outcomes. However, the impact of co-infections, particularly with HIV, on the effectiveness of blood transfusion requires thorough investigation. Beyond its role in addressing anemia, blood transfusion may exert immunomodulatory effects, influencing the host’s immune response to both malaria and HIV. Understanding these interactions is crucial in optimizing transfusion strategies, especially in the context of co-infection. Co-infection with HIV adds another layer of complexity to the management of severe malaria. The potential interactions between blood transfusion and antiretroviral therapy (ART) must be considered, ensuring that both interventions are harmoniously integrated into the treatment plan [27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55].

HIV Co-Infection and Pediatric Severe Malaria

Blood transfusion plays a pivotal role in the management of pediatric severe malaria cases, particularly when complicated by severe anemia. Severe malaria can lead to a rapid decline in hemoglobin levels due to hemolysis, impaired erythropoiesis, and increased red blood cell destruction. In pediatric patients, this anemia can become life-threatening, necessitating prompt intervention. The primary goal of blood transfusion in severe malaria is to restore and maintain adequate oxygen-carrying capacity, thereby preventing vital organ dysfunction and reducing the risk of mortality. Transfusion helps address the immediate consequences of severe anemia, alleviating symptoms such as lethargy, respiratory distress, and impaired consciousness. Additionally, transfusion contributes to the overall management of the disease by supporting the host’s immune response and facilitating the clearance of parasites. However, despite its established role, blood transfusion is not without challenges. Issues such as blood availability, compatibility, and the potential for transfusion-related complications need careful consideration. In malaria- endemic regions, where resources may be limited, ensuring a safe and effective transfusion process is crucial. Moreover, the optimal transfusion threshold and the choice between whole blood and specific blood components remain topics of ongoing research and debate [56, 57, 58, 59, 60, 61, 62].

The co-infection of pediatric severe malaria with HIV introduces additional complexities to the clinical scenario. Both infections independently impact the immune system, and their interaction can lead to reciprocal negative effects. HIV-associated immunosuppression may exacerbate the severity of malaria, making pediatric patients more susceptible to complications. In the context of blood transfusion, the immunological implications of HIV co- infection raise important considerations. While transfusion aims to address severe anemia, the potential impact on the HIV viral load and the immune response to both infections require careful assessment. Studies suggest that blood transfusion may influence the progression of HIV in co- infected individuals, warranting a closer examination of the risks and benefits associated with transfusion therapy in this specific population. Antiretroviral therapy (ART) further complicates the relationship between HIV and severe malaria. The potential interactions between ART and transfusion effectiveness, as well as the influence of ART on the overall clinical outcomes, necessitate thorough investigation [63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74].

Antiretroviral Therapy (ART) and Blood Transfusion

Antiretroviral therapy (ART) has revolutionized the management of HIV infection, significantly improving the life expectancy and quality of life for individuals living with the virus. However, the integration of ART into the treatment landscape becomes particularly intricate when managing pediatric severe malaria cases with concurrent HIV infection. ART functions by suppressing HIV replication, thereby restoring immune function. However, the impact of ART on the immune response to severe malaria remains a complex and evolving area of research. The restoration of immune function may influence the severity and progression of malaria, potentially altering the dynamics of blood transfusion effectiveness. The potential immunomodulatory effects of ART on the course of pediatric severe malaria could influence the need for blood transfusion, potentially reducing the severity of anemia. Conversely, the interplay between ART and malaria treatment may necessitate adjustments to transfusion protocols. The administration of blood transfusion in individuals on ART requires careful consideration. Potential interactions between ART medications and transfused blood components, as well as the impact on the recipient’s overall health, must be evaluated. Close monitoring of transfusion reactions and drug interactions is essential to ensure the safety and efficacy of both interventions [75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94].

The challenge lies in optimizing treatment outcomes by balancing the benefits of blood transfusion in managing severe malaria-associated anemia with the potential complexities introduced by ART [95]. Tailoring transfusion protocols to the individual patient’s immunological and clinical status is crucial, taking into account factors such as HIV viral load, CD4 counts, and the specific ART regimen [96]. Beyond the acute phase of severe malaria, the long-term management of pediatric patients with HIV and a history of severe malaria requires a holistic approach. ART adherence, monitoring for potential drug interactions and ongoing assessment of the patient’s hematological and immunological status are essential components of comprehensive care.

Conclusion

The management of pediatric severe malaria cases with HIV co-infection represents a multifaceted challenge that requires a careful balance between addressing severe anemia, managing the intricacies of co-infection, and considering the potential impact of antiretroviral therapy (ART). This comprehensive review has explored the effectiveness of blood transfusion as a therapeutic intervention in this specific clinical context, aiming to provide insights into the current state of knowledge and identify avenues for future research. Blood transfusion remains a cornerstone in the management of severe malaria-associated anemia, alleviating symptoms, and preventing life-threatening complications. However, the challenges are magnified when pediatric patients are co-infected with HIV. The interplay between these infections introduces complexities related to immunological interactions, potential impacts of ART, and considerations for long-term management.

References

  1. Opeyemi AA, Obeagu EI (2023) Regulations of malaria in children with human immunodeficiency virus infection a review. Medicine 102(46): e36166.
  2. Oyibo WA, Agomo CO (2009) Effects of Malaria and Human Immunodeficiency Virus co-infection during pregnancy. International Journal of Health Science 2(3).
  3. Kapesa A, Kweka EJ, Atieli H, Afrane YA, Kamugisha E, et al. (2018) The current malaria morbidity and mortality in different transmission settings in Western Kenya. PloS one 13(8): e0202031.
  4. Hershey CL, Florey LS, Ali D, Bennett A, Luhanga M, et al. (2017) Malaria control interventions contributed to declines in malaria parasitemia severe anemia and all- cause mortality in children less than 5 years of age in Malawi 2000–2010. Am J Trop Med Hyg 97(3): 76-88.
  5. Obeagu EI, Okwuanaso CB, Edoho SH, Obeagu GU (2022) Under-nutrition among HIV-exposed Uninfected Children A Review of African Perspective. Madonna University journal of Medicine and Health Sciences 2(3): 120-127.
  6. Obeagu EI, Alum EU, Obeagu GU (2023) Factors associated with prevalence of HIV among youths A review of Africa perspective. Madonna University journal of Medicine and Health Sciences 3(1): 13-18.
  7. Obeagu EI (2023) A Review of Challenges and Coping Strategies Faced by HIV/AIDS Discordant Couples. Madonna University journal of Medicine and Health Sciences 3(1): 7-12.
  8. Obeagu EI, Obeagu GU (2023) An update on premalignant cervical lesions and cervical cancer screening services among HIV positive women. J Pub Health Nutri 6(2): 141.
  9. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  10. Omo-Emmanuel UK, Chinedum OK, Obeagu EI (2017) Evaluation of laboratory logistics management information system in HIV/AIDS comprehensive health facilities in Bayelsa State Nigeria. Int J Curr Res Med Sci 3(1): 21-38.
  11. Obeagu EI, Obeagu GU, Musiimenta E, Bot YS, Hassan AO (2023) Factors contributing to low utilization of HIV counseling and testing services. Int J Curr Res Med Sci 9(2): 1-5.
  12. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF (2022) Evaluation of Protein C, Protein S and Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of Medicine and Health Sciences 2(2): 1-9.
  13. Obeagu EI, Ibeh NC, Nwobodo HA, Ochei KC, Iwegbulam CP (2017) Haematological indices of malaria patients coinfected with HIV in Umuahia. Int J Curr Res Med Sci 3(5): 100-104.
  14. Obeagu EI, Chijioke UO, Ekelozie IS (2018) Malaria rapid diagnostic test (RDTs). Ann Clin Lab Res 6(4): 275.
  15. Obeagu EI, Alum EU, Ugwu OP (2023) Hepcidin The Gatekeeper of Iron in Malaria Resistance.
  16. Ogomaka IA, Obeagu EI (2019) Methods of Breast Feeding as Determinants of Malaria Infections among Babies in IMO State Nigeria. International Journal of Medical Science and Dental Research 2(1): 17-24.
  17. Obeagu EI, Obeagu GU, Egba SI, Emeka-Obi OR (2023) Combatting Anemia in Pediatric Malaria Effective Management Strategies. Int J Curr Res Med Sci 9(11): 1-7.
  18. Hassan AO, Oso OV, Obeagu EI, Adeyemo AT (2022) Malaria Vaccine Prospects and Challenges. Madonna University journal of Medicine and Health Sciences 2(2): 22-40.
  19. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, et al. (2021) Prevalence of Malaria with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  20. Obeagu EI, Busari AI, Uduchi IO, Ogomaka IA, Ibekwe AM, et al. (2021) Age-Related Haematological Variations in Patients with Asymptomatic Malaria in Akure Ondo State Nigeria. Journal of Pharmaceutical Research International 33(42B): 218-224.
  21. Ogomaka IA, Obeagu EI (2021) Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs) in Orlu LGA of Imo State, Nigeria. Journal of Pharmaceutical Research International 33(41B): 380- 386.
  22. Ogbonna CO, Obeagu EI, Ufelle SA, Ogbonna LN (2021) Evaluation of Haematological Alterations in Children Infected by Plasmodium Falciparum Species in Enugu Enugu State Nigeria. Journal of Pharmaceutical Research International 33(1): 38-45.
  23. Okorie HM, Obeagu EI, Obarezi HC, Anyiam AF (2019) Assessment of Some Inflammatory Cytokines in Malaria Infected Pregnant Women in Imo State Nigeria. International Journal of Medical Science and Dental Research 2(1): 25-36.
  24. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  25. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Some Haematological Parameters in Malaria Infected Pregnant Women in Imo State Nigeria. Int J Curr Res Biol Med 3(9): 1-4.
  26. Nwosu DC, Obeagu EI, Ezenwuba C, Agu GC, Amah H, et al. (2016) Antioxidant Status of Children with Plasmodium Falciparum Malaria in Owerri Municipal Council of Imo State. Int J Curr Res Chem Pharm Sci 3(8): 40-46.
  27. Obeagu EI, Obeagu GU (2022) An Update on Survival of People Living with HIV in Nigeria. J Pub Health Nutri 5(6): 129.
  28. Offie DC, Obeagu EI, Akueshi C, Njab JE, Ekanem EE, et al. (2021) Facilitators and Barriers to Retention in HIV Care among HIV Infected MSM Attending Community Health Center Yaba Lagos Nigeria. Journal of Pharmaceutical Research International 33(52B): 10-19.
  29. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, et al. (2021) Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  30. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng UE, et al. (2020) TB Infection Control in TB/HIV Settings in Cross River State Nigeria Policy Vs Practice. Journal of Pharmaceutical Research International 32(22): 101- 119.
  31. Obeagu EI, Eze VU, Alaeboh EA, Ochei KC (2016) Determination of Haematocrit Level and Iron Profile Study among Persons Living with HIV in Umuahia Abia State Nigeria. J Bio Innovation 5: 464-471.
  32. Ifeanyi OE, Obeagu GU (2015) The Values of Prothrombin Time among HIV Positive Patients in FMC Owerri. International Journal of Current Microbiology and Applied Sciences 4(4): 911-916.
  33. Izuchukwu IF, Ozims SJ, Agu GC, Obeagu EI, Onu I, et al. (2016) Knowledge of Preventive Measures and Management of HIV/AIDS Victims among Parents in Umuna Orlu Community of Imo State Nigeria. Int J Adv Res Biol Sci 3(10): 55-65.
  34. Chinedu K, Takim AE, Obeagu EI, Chinazor UD, Eloghosa O, et al. (2017) HIV and TB Co-Infection among Patients Who Used Directly Observed Treatment Short Course Centres in Yenagoa Nigeria. IOSR J Pharm Biol Sci 12(4): 70-75.
  35. Oloro OH, Oke TO, Obeagu EI (2022) Evaluation of Coagulation Profile Patients with Pulmonary Tuberculosis and Human Immunodeficiency Virus in Owo Ondo State Nigeria. Madonna University journal of Medicine and Health Sciences 2(3): 110-119.
  36. Nwosu DC, Obeagu EI, Nkwocha BC, Nwanna CA, Nwanjo HU, et al. (2016) Change in Lipid Peroxidation Marker (MDA) and Non enzymatic Antioxidants (VIT C & E) in HIV Seropositive Children in an Urban Community of Abia State. Nigeria J Bio Innov 5(1): 24-30.
  37. Igwe CM, Obeagu IE, Ogbuabor OA (2022) Clinical Characteristics of People Living With HIV/AIDS on ART in 2014 at Tertiary Health Institutions in Enugu Nigeria. J Pub Health Nutri 5(6): 130.
  38. Ifeanyi OE, Obeagu GU, Ijeoma FO, Chioma UI (2015) The Values of Activated Partial Thromboplastin Time (APTT) among HIV Positive Patients in FMC Owerri. Int J Curr Res Aca Rev 3: 139-144.
  39. Obiomah CF, Obeagu EI, Ochei KC, Swem CA, Amachukwu BO (2018) Hematological Indices of HIV Seropositive Subjects in Nnamdi Azikiwe University teaching hospital (NAUTH) Nnewi. Ann Clin Lab Res 6(1): 1-4.
  40. Omo Emmanuel UK, Ochei KC, Osuala EO, Obeagu EI, Onwuasoanya UF (2017) Impact of Prevention of Mother to Child Transmission (PMTCT) of HIV on Positivity Rate in Kafanchan Nigeria. Int J Curr Res Med Sci 3(2): 28-34.
  41. Aizaz M, Abbas FA, Abbas A, Tabassum S, Obeagu EI (2023) Alarming Rise in HIV Cases in Pakistan: Challenges and Future Recommendations at Hand. Health Science Reports 6(8): e1450.
  42. Obeagu EI, Amekpor F, Scott GY (2023) An Update of Human Immunodeficiency Virus Infection: Bleeding Disorders. J Pub Health Nutri 6(1): 139.
  43. Obeagu EI, Scott GY, Amekpor F, Ofodile AC, Edoho SH, et al. (2022) Prevention of New Cases of Human Immunodeficiency Virus: Pragmatic Approaches of Saving Life in Developing Countries. Madonna University journal of Medicine and Health Sciences 2(3): 128-134.
  44. Walter O, Anaebo QB, Obeagu EI, Okoroiwu IL (2022) Evaluation of Activated Partial Thromboplastin Time and Prothrombin Time in HIV and TB Patients in Owerri Metropolis. Journal of Pharmaceutical Research International 34(3A): 29-34.
  45. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng EU, et al. (2020) Cascade variabilities in TB case finding among people living with HIV and the use of IPT: assessment in three levels of care in cross River State, Nigeria. Journal of Pharmaceutical Research International 32(24): 9-18.
  46. Jakheng SP, Obeagu EI (2022) Seroprevalence of Human Immunodeficiency Virus Based on Demographic and Risk Factors among Pregnant Women Attending Clinics in Zaria Metropolis Nigeria. J Pub Health Nutri 5(8): 137.
  47. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, et al. (2017) Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research 5(4): 206.
  48. Anyiam AF, Arinze-Anyiam OC, Omosigho PO, Ibrahim M, Irondi EA, et al. (2022) Blood Group, Genotype, Malaria, Blood Pressure and Blood Glucose Screening Among Selected Adults of a Community in Kwara State: Implications to Public Health. Asian Hematology Research Journal 6(3): 9-17.
  49. Obeagu EI, Nimo OM, Bunu UO, Ugwu OP, Alum EU (2023) Anaemia in Children Under Five Years African Perspectives. Int J Curr Res Biol Med 8(1): 1-7.
  50. Madekwe CC, Madekwe CC, Obeagu EI (2022) Inequality of Monitoring in Human Immunodeficiency Virus, Tuberculosis and Malaria: A Review. Madonna University journal of Medicine and Health Sciences 2(3): 6-15.
  51. Offie DC, Ibekwe AM, Agu CC, Esimai BN, Okpala PU, et al. (2021) Fibrinogen and C-Reactive Protein Significance in Children Infected by Plasmodium falciparum Species in Enugu Enugu State Nigeria. Journal of Pharmaceutical Research International 33(15): 1-8.
  52. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Coagulation Parameters in Malaria Infected Pregnant Women in Imo State Nigeria. International Journal of Current Research in Medical Sciences 4(9): 41-49.
  53. Ogbonna LN, Ezeoru VC, Ofodile AC, Ochiabuto OM, Obi-Ezeani CN, et al. (2021) Gender Based Variations of Haematological Parameters of Patients with Asymptomatic Malaria in Akure Ondo State Nigeria. Journal of Pharmaceutical Research International 33(8): 75-80.
  54. Eberendu IF, Ozims SJ, Agu GC, Amah HC, Obasi CC, et al. (2017) Impact of Human Activities on the Breeding of Mosquitoes of Human Disease in Owerri Metropolis Imo State. Int J Adv Res Biol Sci IJARBS 4(12): 98-106.
  55. Obeagu EI, Ofodile AC, Okwuanaso CB (2023) A Review on Socio Economic and Behavioral Aspects of Malaria and its Control among Children Under 5 Years of Age in Africa. J Pub Health Nutri 6(1): 136.
  56. Obeagu EI, Obeagu GU, Obiezu J, Ezeonwumelu C, Ogunnaya FU, et al. (2023) Hematologic Support in HIV Patients: Blood Transfusion Strategies and Immunological Considerations. Applied Sciences (Nijbas) 3(3).
  57. Obeagu EI, Obeagu GU (2024) The Role of Blood Transfusion Strategies in HIV Management: Current Insights and Future Directions. Elite Journal of Medicine 2(1): 10-22.
  58. Obeagu EI, Obeagu GU (2024) Transfusion Therapy in HIV: Risk Mitigation and Benefits for Improved Patient Outcomes. Sciences 4(1): 32-37.
  59. Obeagu EI, Obeagu GU (2024) Advances in Understanding the Impact of Blood Transfusion on Anemia Resolution in HIV-Positive Children with Severe Malaria A Comprehensive Review. Elite Journal of Haematology 2(1): 26-41.
  60. Obeagu EI, Obeagu GU, Hauwa BA, Umar AI (2024) Hematocrit Variations in HIV Patients Co-infected with Malaria: A Comprehensive Review. International Journal of Innovative and Applied Research 12(1): 12-26.
  61. Obeagu EI, Obeagu GU, Ukibe NR, Oyebadejo SA (2024) Anemia Iron and HIV Decoding the Interconnected Pathways: A Review. Medicine 103(2): e36937.
  62. Obeagu EI, Obeagu GU (2024) Platelet Distribution Width (PDW) as a Prognostic Marker for Anemia Severity in HIV Patients A Comprehensive Review. International Journal of Innovative and Applied Research 12(01).
  63. Obeagu EI, Obeagu GU (2023) A Review of knowledge, Attitudes and Socio Demographic Factors Associated with Non Adherence to Antiretroviral Therapy among People Living with HIV/AIDS. Int J Adv Res Biol Sci 10(9): 135-142.
  64. Obeagu EI, Onuoha EC (2023) Tuberculosis among HIV Patients A Review of Prevalence and Associated Factors. Int J Adv Res Biol Sci 10(9): 128-134.
  65. Obeagu EI, Ibeh NC, Nwobodo HA, Ochei KC, Iwegbulam CP (2017) Haematological Indices of Malaria Patients Coinfected with HIV in Umuahia. Int J Curr Res Med Sci 3(5): 100-104.
  66. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, et al. (2022) Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis Kaduna State Nigeria. South Asian Journal of Research in Microbiology 13(2): 26-31.
  67. Viola N, Kimono E, Nuruh N, Obeagu EI (2023) Factors Hindering Elimination of Mother to Child Transmission of HIV Service Uptake among HIV Positive Women at Comboni Hospital Kyamuhunga Bushenyi District. Asian Journal of Dental and Health Sciences 3(2): 7-14.
  68. Okorie HM, Ifeanyi OE, Okpoli Henry OHC, Nchekwubedi CS (2020) Comparative Study of Enzyme Linked Immunosorbent Assay (Elisa) and Rapid Test Screening Methods on HIV Hbsag Hcv and Syphilis among Voluntary Donors in Owerri Nigeria. J Clin Commun Med 2(3): 180- 183.
  69. Ezugwu UM, Onyenekwe CC, Ukibe NR, Ahaneku JE, Onah CE, et al. (2021) Use of ATP, GTP, ADP and AMP as an Index of Energy Utilization and Storage in HIV Infected Individuals at NAUTH Nigeria A Longitudinal Prospective Case-Controlled Study. Journal of Pharmaceutical Research International 33(47A): 78-84.
  70. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K (2023) Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital Uganda. Asian Journal of Pregnancy and Childbirth 6(1): 203-211.
  71. Igwe MC, Obeagu EI, Ogbuabor AO, Eze GC, Ikpenwa JN, et al. (2022) Socio Demographic Variables of People Living with HIV/AIDS Initiated on ART in 2014 at Tertiary Health Institution in Enugu State. Asian Journal of Research in Infectious Diseases 10(4): 1-7.
  72. Vincent CC, Obeagu EI, Agu IS, Ukeagu NC, Onyekachi Chigbu AC (2021) Adherence to Antiretroviral Therapy among HIV/AIDS in Federal Medical Centre Owerri. Journal of Pharmaceutical Research International 33(57A): 360-368.
  73. Igwe MC, Obeagu EI, Ogbuabor AO (2022) Analysis of the Factors and Predictors of Adherence to Healthcare of People Living With Hiv/Aids in Tertiary Health Institutions in Enugu State. Madonna University journal of Medicine and Health Sciences 2(3): 42-57.
  74. Madekwe CC, Madekwe CC, Obeagu EI (2022) Inequality of monitoring in Human Immunodeficiency Virus Tuberculosis and Malaria A Review. Madonna University journal of Medicine and Health Sciences 2(3): 6-15.
  75. Echendu GE, Vincent CC, Ibebuike J, Asodike M, Naze N, et al. (2023) Weights of Infants Born to Hiv Infected Mothers A Prospective Cohort Study in Federal Medical Centre Owerri Imo State. European Journal of Pharmaceutical and Medical Research 10(8): 564-568.
  76. Nwosu DC, Nwanjo HU, Okolie NJ, Ikeh K, Ajero CM, et al. (2015) Biochemical Alterations in Adult Hiv Patients on Antiretrqviral Therapy. World Journal of Pharmacy and Pharmaceutical Sciences 4(3): 153-160**.**
  77. Obeagu EI, Obeagu GU (2015) Effect of CD4 Counts on Coagulation Parameters among HIV Positive Patients in Federal Medical Centre Owerri Nigeria. Int J Curr Res Biosci Plant Biol 2(4): 45-49.
  78. Obeagu EI, Nwosu DC (2019) Adverse drug reactions in HIV/AIDS patients on highly active antiretro viral therapy a review of prevalence. Int J Curr Res Chem Pharm Sci 6(12): 45-48.
  79. Obeagu EI, Scott GY, Amekpor F, Obeagu GU (2023) Implications of CD4/CD8 ratios in Human Immunodeficiency Virus infections. Int J Curr Res Med Sci 9(2): 6-13.
  80. Obeagu EI, Ochei KC, Okeke EI, Anode AC (2016) Assessment of the level of haemoglobin and erythropoietin in persons living with HIV in Umuahia. Int J Curr Res Med Sci 2(4): 29-33.
  81. Ifeanyi OE, Obeagu GU (2015) The Values of CD4 Count, among HIV Positive Patients in FMC Owerri. Int J Curr Microbiol App Sci 4(4): 906-910.
  82. Obeagu EI, Okeke EI, Anonde Andrew C (2016) Evaluation of haemoglobin and iron profile study among persons living with HIV in Umuahia Abia state Nigeria. Int J Curr Res Biol Med 1(2): 1-5.
  83. Alum EU, Ugwu OP, Obeagu EI, Okon MB (2023) Curtailing HIV/AIDS Spread Impact of Religious Leaders. Newport International Journal of Research in Medical Sciences (NIJRMS) 3(2): 28-31.
  84. Obeagu EI, Obeagu GU, Paul Chima UO (2023) Stigma Associated With HIV AIDS A Review. Newport International Journal of Public Health and Pharmacy (NIJPP) 3(2): 64-67.
  85. Alum EU, Obeagu EI, Ugwu OP, Aja PM, Okon MB (2023) HIV Infection and Cardiovascular diseases The obnoxious Duos. Newport International Journal of Research in Medical Sciences (NIJRMS) 3(2): 95-99.
  86. Ibebuike JE, Nwokike GI, Nwosu DC, Obeagu EI (2018) A Retrospective Study on Human Immune Deficiency Virus among Pregnant Women Attending Antenatal Clinic in Imo State University Teaching Hospital. International Journal of Medical Science and Dental Research 1(2): 08- 14.
  87. Obeagu EI, Obarezi TN, Omeh YN, Okoro NK, Eze OB (2014) Assessment of some haematological and biochemical parametrs in HIV patients before receiving treatment in Aba Abia State Nigeria. Res J Pharma Biol Chem Sci 5(2): 825-830.
  88. Obeagu EI, Obarezi TN, Ogbuabor BN, Anaebo QB, Eze GC (2014) Pattern of total white blood cell and differential count values in HIV positive patients receiving treatment in Federal Teaching Hospital Abakaliki, Ebonyi State Nigeria. International Journal of Life Science Biotechnology and Pharama Research 3(1): 186-189.
  89. Obeagu EI (2023) A Review of Challenges and Coping Strategies Faced by HIV/AIDS Discordant Couples. Madonna University journal of Medicine and Health Sciences. 3(1): 7-12.
  90. Oloro OH, Obeagu EI (2022) A Systematic Review on Some Coagulation Profile in HIV Infection. International Journal of Innovative and Applied Research 10(5): 1-11.
  91. Nwosu DC, Obeagu EI, Nkwuocha BC, Nwanna CA, Nwanjo HU, et al. (2015) Alterations in superoxide dismutiase vitamins C and E in HIV infected children in Umuahia Abia state. International Journal of Advanced Research in Biological Sciences 2(11): 268-271.
  92. Obeagu EI, Malot S, Obeagu GU, Ugwu OP (2023) HIV resistance in patients with Sickle Cell Anaemia. Newport International Journal of Scientific and Experimental Sciences (NIJSES) 3(2): 56-59.
  93. Ifeanyi OE, Uzoma OG, Stella EI, Chinedum OK, Abum SC (2018) Vitamin D and insulin resistance in HIV sero positive individuals in Umudike. Int J Curr Res Med Sci 4(2): 104-108.
  94. Ifeanyi OE, Leticia OI, Nwosu D, Chinedum OK (2018) A Review on blood borne viral infections universal precautions. Int J Adv Res Biol Sci 5(6): 60-66.
  95. Mvango S, Matshe WM, Balogun AO, Pilcher LA, Balogun MO (2018) Nanomedicines for malaria chemotherapy encapsulation vs polymer therapeutics. Pharm Res 35(12): 1-27.
  96. Nance RM, Delaney JC, Simoni JM, Wilson IB, Mayer KH, et al. (2018) HIV viral suppression trends over time among HIV infected patients receiving care in the United States 1997 to 2015 a cohort study. Ann Intern Med 169(6): 376-384.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{emmanuel2024,
  title   = {The Impact of Blood Transfusion on Pediatric Severe Malaria Cases with HIV Co Infection A Review},
  author  = {Emmanuel Ifeanyi Obeagu * and Getrude Uzoma Obeagu},
  journal = {Pediatrics & Neonatal Biology Open Access},
  year    = {2024},
  volume  = {9},
  number  = {1},
  doi     = {10.23880/pnboa-16000194}
}
Emmanuel Ifeanyi Obeagu * and Getrude Uzoma Obeagu (2024). The Impact of Blood Transfusion on Pediatric Severe Malaria Cases with HIV Co Infection A Review. Pediatrics & Neonatal Biology Open Access, 9(1). https://doi.org/10.23880/pnboa-16000194
TY  - JOUR
TI  - The Impact of Blood Transfusion on Pediatric Severe Malaria Cases with HIV Co Infection A Review
AU  - Emmanuel Ifeanyi Obeagu * and Getrude Uzoma Obeagu
JO  - Pediatrics & Neonatal Biology Open Access
PY  - 2024
VL  - 9
IS  - 1
DO  - 10.23880/pnboa-16000194
ER  -